Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer? Academic Article Article uri icon

Overview

MeSH Major

  • Autophagy
  • Immunotherapy
  • Neoplasms

abstract

  • We found no evidence that the risk of breast cancer associated with EPRT is limited to subgroups of women with specific cofactors. Tumors in EPRT users are more often hormone receptor--positive, indicating that they may have a better prognosis than breast cancer overall.

publication date

  • February 2002

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1200/JCO.20.3.699

PubMed ID

  • 11821451

Additional Document Info

start page

  • 699

end page

  • 706

volume

  • 20

number

  • 3